Research news last week included US biotech Fate releasing early data for its FT819 in the treatment of systemic lupus ...

Japanese mid-size drugmaker Otsuka Pharmaceutical announced that it has entered into an exclusive worldwide licensing ...

Japanese drugmaker Chugai, which is majority owned by Roche, On Friday revealed that Zenyaku Kogyo has obtained regulatory ...

US healthcare giant Johnson & Johnson has filed a supplemental Biologics License Application with the US Food and Drug ...

Colorado, USA-based OncoVerity announced the closing of a series A extension led by existing investors, argenX and ...

The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human ...

Japanese drugmaker Takeda (TYO: 4502) has launched Fruzaqla (fruquintinib) in its home country. This follows the approval of ...

Sino Biopharm has invested $20 million to acquire a 4.91% stake in LaNova Medicines, securing rights to LM-108 and other ...

California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up ...

Germany’s Evotec says it has taken notice of the statement made by Halozyme Therapeutics on November 22, stating that it has withdrawn its non-binding proposal to acquire Evotec for 11.00 euros per ...

Zai Lab and Pfizer have partnered for the commercialization of Xacduro (sulbactam-durlobactam) in China, targeting carbapenem ...

Akeso is awaiting approval from China's medicines regulator for a penpulimab-anlotinib combination therapy for advanced liver ...